INTRODUCTION
============

*Vibrio cholerae* causes the diarrhoeal disease cholera ([@r29]) and is a natural inhabitant of aquatic ecosystems ([@r13]). *V. cholerae*\'s ability to cause epidemics is linked to its ability to survive in its natural habitats, which is enhanced by its ability to form matrix-enclosed, surface-associated communities, known as biofilms ([@r1]; [@r13]). In aquatic habitats, *V. cholerae* can be isolated from surfaces of phytoplankton, zooplankton, aquatic plants, crustaceans and insects, as well as sediments ([@r7]; [@r20]; [@r26], [@r27], [@r28]), and biofilm formation facilitates environmental survival of the pathogen. Biofilms are also critical for the transmission and infectivity of *V. cholerae*. Removal of particles \>20 μm in diameter from water can reduce cholera incidence ([@r10]; [@r25]). Furthermore, stool samples of cholera patients contain both biofilm-like aggregates and planktonic forms of *V. cholerae* ([@r14]), and the average infectivity of the aggregate form is significantly higher than that of planktonic cells ([@r14]). Altogether, these studies indicate the importance of the biofilm growth mode in both the intestinal and aquatic phases of *V. cholerae*\'s life cycle.

Formation of mature biofilms requires the production of extracellular matrix components. A major component of the *V. cholerae* biofilm matrix is VPS (*[V]{.ul}ibrio* [p]{.ul}oly[s]{.ul}accharide) exopolysaccharide, which is required for the formation of mature biofilm structures ([@r55]), while matrix proteins, in particular RbmA, RbmC and Bap1, are required for maintaining the structural integrity of the wild-type biofilm ([@r15]; [@r17]). VPS was first isolated from a rugose wild-type strain of *V. cholerae* that exhibited enhanced capacity to produce VPS, and consequently enhanced biofilm formation compared to the smooth wild-type strain. VPS of *V. cholerae* O1 El Tor strain A1552 contains glucose, galactose, *N*-acetylglucosamine and mannose, and the genes required for VPS synthesis were identified through transposon mutagenesis ([@r55]). The *vps* genes are clustered in two regions on the large chromosome of *V. cholerae* O1 El Tor \[*vpsU* (VC0916), *vpsA--K* (VC0917--27) (*vps-*I cluster); and *vpsL--Q* (VC0934--9) (*vps-*II cluster)\]. However, it is not known if all the genes within the *vps*-I and *vps*-II clusters are required for biofilm formation and VPS production.

Several studies suggest that VPS is produced during infection and could contribute to *in vivo* colonization and survival. It has been shown that *vpsH* (VC0924), involved in VPS production, is induced during *in vivo* growth in an infant mouse model system ([@r35]). Furthermore, an *in vivo* expression technology (IVET) screen performed in human volunteers to identify genes expressed during infection revealed that several *vps* genes, namely *vpsA* (VC0917), *vpsB* (VC0918), *vpsC* (VC0919) and *vpsN* (VC0936), are expressed during human infection ([@r37]). *In vivo*-induced antigen technology (IVIAT) has also shown that sera from cholera patients recognize VpsH (VC0924), which is required for VPS production ([@r21]). [@r24] reported that bile acids stimulate *vps* transcription and *in vitro* biofilm formation. A recent study has also shown that both planktonic and aggregated forms (which are predicted to result from *in vivo* biofilms) of *V. cholerae* are shed in human stools ([@r14]). In addition, it was recently shown that VpsR, the master regulator of biofilm formation and *vps* expression, directly activates transcription of *aphA*, which encodes a positive transcriptional regulator of virulence gene expression in *V. cholerae* ([@r36]). Taken together, these studies strongly suggest that *vps* genes are expressed and probably important *in vivo*.

In this study, we generated in-frame deletions of all the *vps* genes located in the *vps*-I and *vps*-II clusters and determined the role of these VPS proteins in biofilm formation and VPS biosynthesis. We also analysed the contribution of VPS and matrix proteins to *in vivo* fitness of *V. cholerae*.

METHODS
=======

Bacterial strains, plasmids and culture conditions.
---------------------------------------------------

The bacterial strains and plasmids used in this study are listed in Table [1](#t1){ref-type="table"}. All *V. cholerae* and *Escherichia coli* strains were routinely grown aerobically in Luria--Bertani (LB) medium (1 % tryptone, 0.5 % yeast extract, 1 % NaCl) at 30 °C and 37 °C respectively, unless otherwise noted. Agar medium contained 1.5 % granulated agar (Difco). Concentrations of antibiotics used were as follows: ampicillin, 100 μg ml^−1^; rifampicin, 100 μg ml^−1^; gentamicin, 50 μg ml^−1^.

Recombinant DNA techniques.
---------------------------

Restriction enzymes, DNA modification enzymes and Phusion High-Fidelity DNA polymerase were purchased from New England Biolabs. PCRs were carried out with primers purchased from Bioneer USA Corporation, listed in Supplementary Table S1, available with the online version of this paper. DNA sequencing was carried out by the Sequetech Corporation.

Generation of in-frame deletion mutants.
----------------------------------------

Deletion mutants were generated according to the protocol previously published ([@r17]; [@r19]). The DNA sequences of the constructed deletion plasmids were verified by DNA sequencing.

Colony morphology and pellicle formation analyses.
--------------------------------------------------

For analysis of corrugated colony morphology development, cultures grown overnight at 30 °C with shaking (200 r.p.m.) were serially diluted with LB medium and 100 μl aliquots of the diluted cultures were plated onto LB agar medium. The cultures were incubated at 30 °C for 2 days. For analysis of pellicle formation, glass culture tubes (18×150 mm) containing 5 ml LB medium were inoculated with overnight-grown cultures, resulting in a 200-fold dilution. The tubes were incubated at 30 °C under non-shaking conditions for 2 days. Assays were repeated with at least two different biological replicates.

VPS immunoblot assays.
----------------------

Isolation of crude VPS from wild-type and mutant strains and immunoblot analyses of the extracted VPS were carried out according to a protocol similar to those previously published ([@r12]; [@r15]; [@r55]). Briefly, overnight-grown cultures on LB agar medium were harvested and resuspended in PBS. Normalization was carried out by adjusting each culture to the same OD~600~, measured with a Beckman Du Series 500 spectrophotometer. Equal volumes of the cultures were pipetted into Erlenmeyer flasks and the suspension was incubated overnight at 4 °C, shaking at 100 r.p.m. Crude VPS supernatant was separated from the bacterial cells and debris by centrifugation twice at 20 000 ***g*** for 30 min and precipitated with 3 volumes of ethanol at −20 °C overnight. Crude VPS was pelleted by centrifugation at 20 000 ***g*** for 30 min, washed with 70 % ethanol, air-dried and resuspended in 500 μl water. Purified VPS from the wild-type rugose variant was used as a positive control and for quantification. Purified VPS was isolated as described above with additional purification steps published previously ([@r15]). Briefly, crude VPS pellet was resuspended in nuclease buffer (40 mM Tris/HCl pH 8.0, 10 mM MgCl~2~, 2 mM CaCl~2~, 0.05 % NaN~3~). DNase I and RNase A were added to the VPS suspension at final concentrations of 2 units ml^−1^ and 50 μg ml^−1^, respectively, followed by incubation at 37 °C shaking for 8 h. Proteinase K was then added at a final concentration of 200 μg ml^−1^, and the suspension was further incubated with shaking overnight at 37 °C. Phenol/chloroform extractions (equal volumes) were carried out, followed by precipitation with 3 volumes of ethanol, washing with 70 % ethanol, and solubilization in water. Detoxi-Gel endotoxin-removing gel (Pierce) was used to remove contaminating lipopolysaccharides (LPS) according to the manufacturer\'s instructions and the purified VPS suspension was dialysed with water at 4 °C overnight using a Slide-A-Lyser 3.5K MWCO dialysis cassette (Pierce). The VPS suspension was then dried using a Micro Modulyo freeze-drier (Thermo Savant), the dry weight of the VPS sample was determined and the dried purified VPS was resolubilized in water. Crude and purified VPS (3 μl) was spotted onto nitrocellulose membranes and immunoblot analyses were carried out using anti-VPS antiserum and goat anti-rabbit horseradish-peroxidase-conjugated antibody. The immunoblots were developed with the SuperSignal West Pico chemiluminescent kit (Pierce) and quantified using ImageQuant 5.2 software (Molecular Dynamics). VPS immunoblot analyses were carried out with two different biological replicates and at least three technical replicates. It should be noted that the VPS antibody used in this study is polyclonal, with undefined epitopes. As such, the immunoblot assay was used as a phenotypic screen to identify mutants that cannot produce 'wild-type' VPS and not for determining the effect of a given mutation on the VPS structure.

Quantitative biofilm assays.
----------------------------

Biofilm formation assays were carried out in PVC microtitre plates (BD Falcon) with 100 μl of overnight-grown cultures diluted to an OD~600~ of 0.04. The microtitre plates were incubated at 30 °C for 8 h. Crystal violet staining and ethanol solubilization were carried out as previously described ([@r17]; [@r56]). Absorbance of the solubilized crystal violet stain was measured at 595 nm using a VersMax Tunable Microplate Reader (Molecular Devices). The assays were repeated with at least two different biological replicates and at least five technical replicates.

Generation of GFP-tagged strains and confocal scanning laser microscopy (CSLM).
-------------------------------------------------------------------------------

*V. cholerae* wild-type and deletion strains were tagged with green fluorescent protein (GFP) according to the procedure previously described ([@r17]). Flow-cell experiments were carried out at room temperature as described previously ([@r5]). Images were acquired using a Zeiss Axiovert 200 M laser scanning microscope. 3D images of the biofilms were reconstructed using [imaris]{.smallcaps} software (Bitplane) and quantified using [comstat]{.smallcaps} ([@r23]). Experiments were carried out with at least two biological replicates.

Infection studies.
------------------

The infant mouse intestinal colonization model system was used in the single-strain infection experiment. Oral administration of 10^6^ exponential-phase *V. cholerae* wild-type variants or deletion mutants (unable to produce biofilm matrix components) to 4--5-day-old CD-1 suckling mice was carried out. At 20 h post-infection, the mice were sacrificed and their small intestines were removed and homogenized. Intestinal homogenates were serially diluted and plated onto selective agar. The number of bacteria per intestine was quantified by colony counting and used to determine intestinal colonization of the mutant strain. One-way ANOVA (Kruskal--Wallis test) was performed to determine statistically significant differences. Individual groups were then compared using the Mann--Whitney non-parametric *t*-test; a *P*-value of ≤0.05 was considered significant (Prism 5, GraphPad Software).

RESULTS AND DISCUSSION
======================

Molecular analysis of *vps* gene clusters
-----------------------------------------

A major component of *V. cholerae* biofilm matrix is the VPS exopolysaccharide. VPS production is mediated by proteins encoded by the *vps* genes, which are organized into *vps-*I and *vps-*II clusters on the large chromosome, separated by an 8.3 kb intergenic region containing six genes ([@r15]; [@r17]; [@r55]). There are 18 *vps* genes, 12 of which are located in the *vps-*I cluster (*vpsU*, VC0916; *vpsA--K*, VC0917--27), while the other six are located in the *vps-*II cluster (*vpsL-Q*, VC0934--9) (Fig. [1](#f1){ref-type="fig"}). To determine if all the *vps* gene products are required for biofilm formation, we generated in-frame deletion mutants for each *vps* gene in the wild-type rugose genetic background (hereafter referred as RΔ). We also constructed mutant strains containing deletions of the first and/or second *vps* clusters \[RΔ*vps*-I (*vpsA*--*K*), RΔ*vps*-II (*vpsL*--*Q*) and RΔ*vps*-IΔ*vps*-II\]. We then characterized the mutants for colony morphology, pellicle formation, biofilm formation and VPS production (Table [2](#t2){ref-type="table"}). It is important to note that the deletion strains do not exhibit growth defects when compared to the parental wild-type strain (data not shown).

The rugose wild-type forms corrugated colonies (Fig. [2](#f2){ref-type="fig"}) and a robust pellicle (Fig. [3](#f3){ref-type="fig"}), and has increased capacity to form a biofilm (Fig. [4a](#f4){ref-type="fig"}) and produce VPS (Fig. [4b, c](#f4){ref-type="fig"}). We termed these phenotypes 'rugosity-associated phenotypes'. Mature biofilm formed by the rugose wild-type also exhibited the characteristic elaborate 3D structures as analysed by CSLM (Fig. [5](#f5){ref-type="fig"}). We first characterized strains lacking the *vps* clusters (RΔ*vps*-I, RΔ*vps*-II and RΔ*vps*-IΔ*vps*-II). These mutant strains formed flat and smooth colonies (Fig. [2](#f2){ref-type="fig"}), and exhibited a marked decrease in the production or secretion of VPS (Fig. [4b, c](#f4){ref-type="fig"}), and reduction in the ability to form pellicles (Fig. [3](#f3){ref-type="fig"}) and biofilms (Fig. [4a](#f4){ref-type="fig"}). CSLM analysis of biofilms of the rugose wild-type and RΔ*vps*-IΔ*vps*-II revealed that the latter is unable to form the elaborate 3D mature biofilm structures (Fig. [5](#f5){ref-type="fig"}). [comstat]{.smallcaps} analysis revealed that total biomass, and mean and maximum thicknesses, are lower in RΔ*vps*-IΔ*vps*-II compared to the rugose wild-type, particularly after 24 h (Table [3](#t3){ref-type="table"}). Strains carrying in-frame deletions of either the *vps*-I or *vps*-II cluster also form biofilms resembling that of RΔ*vps*-IΔ*vps*-II (data not shown).

We then analysed the rugosity-associated phenotypes of the individual *vps* deletion mutants. Based on the predicted amino acid sequences and domains of the *vps* gene products and their predicted functions, we can group these VPS proteins into six classes (Table [2](#t2){ref-type="table"}). Class I consists of proteins that are predicted to be required for production of nucleotide sugar precursors. VpsA is predicted to encode UDP-*N*-acetylglucosamine 2-epimerase while VpsB is predicted to encode UDP-*N*-acetyl-[d]{.smallcaps}-mannosaminuronic acid dehydrogenase. UDP-*N*-acetylglucosamine 2-epimerase catalyses the interconversion of UDP-*N*-acetyl-[d]{.smallcaps}-glucosamine to UDP-*N*-acetyl-[d]{.smallcaps}-mannosamine. The latter is then converted to UDP-*N*-acetyl-[d]{.smallcaps}-mannosaminuronic acid by UDP-*N*-acetyl-[d]{.smallcaps}-mannosamine/mannosaminuronic acid dehydrogenase ([@r30], [@r31]). Since VpsA and VpsB are predicted to be involved in the production of nucleotide sugar precursors, it is not surprising that deletion of *vpsA* and *vpsB* resulted in strains that exhibited decreased colony corrugation (Fig. [2](#f2){ref-type="fig"}) and reduction in the ability to form pellicle (Fig. [3](#f3){ref-type="fig"}), biofilm and VPS (Fig. [4](#f4){ref-type="fig"}).

Class II consists of four predicted glycosyltransferases encoded by *vpsD*, *vpsI*, *vpsK* and *vpsL*. VpsD and VpsI are classified as members of the glycosyltransferase family 4 (GT4), while VpsK is classified as a member of GT26 in the Carbohydrate Active Enzymes (CAZY) database (<http://www.cazy.org>) ([@r9]). Although VpsL is not classified as part of any GT family, the Universal Protein Resource (UniProt) database (<http://www.uniprot.org/>) shows that VpsL contains a bacterial sugar transferase domain (PF02397), suggesting that VpsL is probably a glycosyltransferase. Glycosyltransferases catalyse the transfer of sugar moieties to specific acceptor molecules ([@r8]; [@r54]), forming glycosidic bonds that are predicted to be involved in initiation and/or elongation of VPS subunits (repeat units). Thus, the mutants lacking glycosyltransferase activity are unlikely to produce mature VPS. As expected, strains containing in-frame deletion of these genes (RΔ*vpsD*, RΔ*vpsI*, RΔ*vpsK* and RΔ*vpsL*) exhibited flat and smooth colony morphology (Fig. [2](#f2){ref-type="fig"}). These mutants were also unable to form a pellicle (Fig. [3](#f3){ref-type="fig"}), and exhibited a significant reduction in biofilm formation and were unable to produce VPS (Fig. [4](#f4){ref-type="fig"}).

Class III consists of proteins encoded by *vpsE*, *vpsH*, *vpsN* and *vpsO* that are predicted to be involved in VPS polymerization and export. VpsE contains a predicted polysaccharide synthesis domain (PF01943), which is also found in Wzx-like proteins that are O-antigen translocases involved in LPS export in *E. coli* ([@r38], [@r39]; [@r53]). Besides the presence of the loosely conserved PF01943 domain, there is very low conservation in the protein primary sequence in these Wzx-like proteins ([@r39]). Interestingly, PelG from *Pseudomonas aeruginosa,* which is involved in biofilm formation, has also been described as a Wzx-like polysaccharide transporter ([@r49]). Based on computational analysis, VpsE is likely to be a polysaccharide export protein. VpsH is annotated as a putative CapK protein in The Institute for Genomic Research Comprehensive Microbial Resource (TIGR-CMR) and UniProt databases. CapK in *Staphylococcus aureus* is reported to be a possible capsular polysaccharide polymerase ([@r45]). VpsN is predicted by the UniProt database to encode a polysaccharide export-related protein that contains a polysaccharide export domain (PF02563), also associated with the Wzx-like proteins, suggesting that VpsN may also be involved in polysaccharide export. VpsO is predicted by the UniProt database to contain a PF02706 domain associated with the *E. coli* chain length determinant protein Wzz ([@r18]).

Mutants in class III may produce lipid-linked subunits of VPS, but not full-length VPS. If VPS transport takes place after complete polymerization in the cytoplasm or periplasm, VPS could accumulate in the cytoplasm or periplasm. Alternatively, unpolymerized or partially polymerized VPS may be secreted. Mutants lacking functional VpsE, VpsN and VpsO produced flat and smooth colonies (Fig. [2](#f2){ref-type="fig"}), were unable to form a pellicle (Fig. [3](#f3){ref-type="fig"}), and exhibited drastic reduction in biofilm formation and VPS production (Fig. [4](#f4){ref-type="fig"}). Although a mutant lacking functional VpsH (RΔ*vpsH*) exhibited smooth colony morphology, it is important to note that the colony is more compact compared to the *vps*-clusters deletion mutants. Furthermore, RΔ*vpsH* formed a pellicle with altered structures (Fig. [3](#f3){ref-type="fig"}, top panels) and exhibited a moderate decrease in biofilm formation (Fig. [4a](#f4){ref-type="fig"}). In addition, RΔ*vpsH* produced much less VPS than the rugose wild-type, but not as little as the *vps*-cluster deletion mutants (Fig. [4b, c](#f4){ref-type="fig"}), suggesting that production of VPS intermediates may still occur in RΔ*vpsH*.

Class IV consists of proteins that are encoded by *vpsC* and *vpsG*. VpsC and VpsG are predicted to be acetyltransferases involved in the addition of acetyl groups to polysaccharide. Mutants lacking the acetyltransferases were expected to produce VPS without acetyl modifications, which are likely to have different biophysical properties from those of the wild-type. RΔ*vpsG* exhibited a significant reduction in colony corrugation but the colonies were not completely flat and smooth (Fig. [2](#f2){ref-type="fig"}). RΔ*vpsG* also formed a pellicle with altered structure (Fig. [3](#f3){ref-type="fig"}, top panel), and showed reduced biofilm formation and VPS production (Fig. [4](#f4){ref-type="fig"}). In contrast, RΔ*vpsC* retained its rugose colony corrugation (Fig. [2](#f2){ref-type="fig"}), formed a pellicle with structure similar to the rugose variant (Fig. [3](#f3){ref-type="fig"}) and did not exhibit significant defects in biofilm formation on solid surfaces or VPS production (Fig. [4](#f4){ref-type="fig"}). The structural modification of alginate by *O*-acetylation alters its physical properties, including viscosity ([@r42]). *O*-Acetyl groups are required for the formation of mature biofilm structures in alginate-producing mucoid *P. aeruginosa* strains, as well as for maintenance of chronic *P. aeruginosa* infections ([@r43]). VPS is highly viscous, and thus non-acetylated VPS may have reduced viscosity, affecting biofilm structure and stability. While the altered rugosity-associated phenotypes exhibited by RΔ*vpsG* are expected, it is surprising that RΔ*vpsC* formed colonies and pellicles that resemble those of the rugose parent. We also generated a strain carrying in-frame deletions of both *vpsC* and *vpsG*. This double mutant exhibited phenotypes similar to those of the single *vpsG* mutant (Figs [2](#f2){ref-type="fig"}, [3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). It is possible that VpsC is not a functional acetyltransferase, or that VpsG and VpsC may be required for the modification of different portions of the VPS, or even that these different acetyltransferase may be required at different stages of biofilm formation. We are currently testing these hypotheses.

Class V consists of the phosphotyrosine-protein phosphatase encoded by *vpsU*, and deletion of *vpsU* resulted in a strain with altered colony morphology (Fig. [2](#f2){ref-type="fig"}), pellicle structure (Fig. [3](#f3){ref-type="fig"}), biofilm formation and VPS production (Fig. [4](#f4){ref-type="fig"}). Phosphotyrosine-protein phosphatases catalyse the dephosphorylation of tyrosine-phosphorylated proteins ([@r32]). A number of phosphotyrosine-protein phosphatases in both Gram-positive and Gram-negative bacteria have been identified ([@r40], [@r41]; [@r46]; [@r50]), and have been shown to be involved in regulation of exopolysaccharide production ([@r40]; [@r51]). The phosphotyrosine-protein phosphatases found in Gram-negative bacteria usually contain two conserved active-site sequence motifs (C-X~4~-C-R and D-P-Y) ([@r32]; [@r47]; [@r50]), while those found in Gram-positive bacteria usually contain four conserved motifs ([@r2]; [@r41]), except for PtpA and PtpB from *S. aureus*, which resemble phosphotyrosine-protein phosphatases found in Gram-negative bacteria ([@r46]). Alignment of VpsU (*V. cholerae*), Wzb (*E. coli*), PtpA (*P. aeruginosa* PAO1) and PtpAB (*S. aureus*) indeed showed that VpsU contains the two active-site motifs conserved in other similar phosphotyrosine-protein phosphatases (data not shown). The altered rugosity-associated phenotypes exhibited by RΔ*vpsU* indicate a role of VpsU in VPS production, although the target for VpsU remains to be determined. In *E. coli*, Wzb (phosphotyrosine-protein phosphatase) and Wzc (protein-tyrosine kinase) function together in the production of the capsular polysaccharide colanic acid ([@r51]). Although the UniProt database suggested that VpsO is similar to the chain length determinant protein Wzz based on the presence of a PF02706 domain, [blastp]{.smallcaps} search using Wzc peptide sequence identified VpsO as the top match (*E*-value 4.6×10^−22^), suggesting that VpsO may be the target of VpsU. We are currently investigating this hypothesis.

Class VI consists of hypothetical proteins encoded by *vpsF*, *vpsJ*, *vpsM*, *vpsP* and *vpsQ*. While RΔ*vpsP* and RΔ*vpsQ* strains produce VPS and form colonies, pellicles and biofilms similar to those of the wild-type, other mutants lacking *vpsF*, *vpsJ* and *vpsM* exhibited complete loss of colony corrugation, inability to form pellicle and drastic reduction in biofilm formation and VPS production (Figs [2](#f2){ref-type="fig"}, [3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). Since *vpsF*, *vpsJ* and *vpsM* are predicted to encode hypothetical proteins, identifying the roles of these hypothetical proteins in building the biofilm matrix is critical.

Collectively, phenotypic analysis of the *vps* mutants shows that, under our experimental conditions, most of the VPS proteins are required for wild-type rugose colony corrugation, pellicle and biofilm formation, and VPS production.

Role of biofilm matrix components in *in vivo* fitness
------------------------------------------------------

*V. cholerae* biofilm formation inside the host and its contribution to pathogenesis is not well understood. While some biofilm-related factors have been studied for their roles in *V. cholerae* intestinal colonization ([@r34]; [@r44]; [@r52]; [@r57]), different research groups have obtained contradictory results regarding the importance of these factors. For example, mutants lacking VpsR, a positive transcriptional regulator of biofilm matrix production, have given variable results for mouse infection, including normal and decreased colonization ([@r44]; [@r48]). In another study, a rugose variant (resulting from *flaA* deletion) was found to be defective for infant mouse intestinal colonization in a competition infection, suggesting that a high level of VPS production is detrimental ([@r52]). It is therefore evident that many factors, possibly including the presence of VPS and matrix proteins, affect *in vivo* fitness of *V. cholerae*.

To this end, we carried out experiments to investigate whether known biofilm determinants in *V. cholerae* contribute to pathogenesis. We initially performed competition experiments using the smooth (low-biofilm-forming) and rugose (high-biofilm-forming) wild-type variants in the commonly used infant mouse model, but did not see a significant difference in the competitive index (data not shown). We reasoned that competition assays alone may be misleading, as VPS produced by the rugose variant could complement the co-inoculated strain *in trans*, thus masking differences in *in vivo* fitness. Therefore, we performed single-strain infections in the infant mouse model. We first compared the colonization capacities of smooth and rugose wild-type variants. As shown in Fig. [6](#f6){ref-type="fig"}, the rugose variant colonized the intestine better (approx. 3.6-fold) than the smooth variant. These data suggest that matrix components contribute to colonization and increase *in vivo* fitness, since the rugose variant produces more biofilm matrix than the smooth variant. To test this hypothesis, we compared the colonization capacity of the rugose wild-type variant to those of a mutant that is incapable of producing VPS (RΔ*vps*-IΔ*vps*-II) and mutants that are unable to produce matrix proteins (RΔ*rbmA* and RΔ*rbmC*Δ*bap1*). RbmA, RbmC and Bap1 matrix proteins modulate rugosity-associated phenotypes ([@r15]; [@r17]). RbmC and Bap1 share 46.7 % peptide sequence similarity and appear to be partially redundant. Deletion of *rbmA* and *bap1* in the rugose genetic background resulted in strains with altered colony morphology and biofilm formation when compared to the rugose wild-type ([@r15]; [@r17]). Although deletion of *rbmC* (a homologue of *bap1*) in the rugose genetic background did not alter the colony morphology and biofilm formation significantly, the double deletion mutant RΔ*rbmC*Δ*bap1* exhibited a marked decrease in biofilm formation ([@r15]).

We determined that RΔ*vps*-IΔ*vps*-II exhibited a severe defect in intestinal colonization, with a 9.4-fold lower c.f.u. recovery compared to the rugose variant. This result indicates that VPS production increases *in vivo* fitness. The mutant lacking the biofilm matrix protein RbmA also exhibited a defect in intestinal colonization, with a 4.1-fold lower c.f.u. recovery. This outcome indicates that VPS and RbmA contribute significantly to *in vivo* fitness of *V. cholerae* in these models, and that they contribute to biofilm formation in both *in vivo* and aquatic environments. In contrast, there was no significant difference in the colonization ability of the RΔ*rbmC*Δ*bap1* double mutant when compared to the rugose variant, indicating that either RbmC and Bap1 do not significantly influence intestinal colonization, or their phenotype is not evident under the experimental conditions utilized, thus suggesting that the major function of these biofilm matrix proteins is in the formation of biofilms in aquatic environments. Collectively, these results indicate that the biofilm matrix components are important in *in vitro* biofilm formation, and that VPS and RbmA also contribute to *in vivo* fitness of *V. cholerae*.

The results presented in this study have revealed how the various *vps* gene products contribute to wild-type biofilm formation and VPS biosynthesis, and have laid the groundwork for future biochemical characterization of the VPS biosynthetic pathway. *In vitro* experiments carried out with the *vps* mutants in this study, and *rbm* mutants in previous studies, clearly demonstrate the importance of matrix components, both VPS and matrix proteins, in the building of a robust wild-type biofilm. In-frame deletion of 15 of the 18 *vps* genes resulted in strains that exhibited drastic altered rugosity-associated phenotypes (Figs [2](#f2){ref-type="fig"}, [3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). VPS and RbmA also contribute to *in vivo* fitness of *V. cholerae,* as shown in *in vivo* mouse colonization studies, where mutants not able to produce VPS or RbmA were defective for intestinal colonization (Fig. [6](#f6){ref-type="fig"}).

Humans ingest *V. cholerae* biofilms as part of the pathogen\'s normal transmission route. In this study, we have shown that VPS and biofilm matrix proteins are critical for *in vitro* biofilm formation and are also important for *in vivo* fitness. The nature of the VPS coating and matrix proteins in the biofilms may influence the progression of the disease, and/or development of an immune response against *V. cholerae*. A better understanding of biofilm matrix biosynthesis and function could allow us to develop inhibitors that specifically alter the matrix properties and affect either *ex vivo* (aquatic) survival or *in vivo* pathogenesis.

-   CSLM, confocal scanning laser microscopy

-   VPS, *Vibro* polysaccharide
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![Genomic organization of genes involved in VPS and matrix protein production in *V. cholerae*. Loci of the genes encoding proteins involved in VPS biosynthesis (*vps*-I and *vps*-II clusters) and genes encoding matrix proteins (*rbm* cluster and *bap1*) on the *V. cholerae* chromosome are depicted. Arrows represent genes predicted to be involved in VPS biosynthesis (black), encoding hypothetical proteins (grey) and encoding matrix proteins RbmA, RbmC and Bap1 (hatched), and other genes found in the *vps*-intergenic region (white arrows). Unlinked chromosomal DNA region is indicated (\|\|). Illustration is not to scale.](2757fig1){#f1}

![Colony morphology of *vps* deletion mutants. Colony pictures of rugose wild-type and *vps* deletion mutants were taken after cultures had been incubated at 30 °C for 2 days. The assay was repeated with two biological replicates. Scale bars represent 0.5 mm.](2757fig2){#f2}

![Pellicle formation in *vps* deletion mutants. Pellicle pictures of rugose wild-type and *vps* deletion mutants from the top (top panels) and side (lower panels) of the cultures were taken after 2 days of incubation at 30 °C. The assay was repeated with two biological replicates.](2757fig3){#f3}

![Biofilm formation and VPS production in *vps* mutants. (a) Biofilm-forming capacities of the rugose wild-type and *vps* mutants were determined using the crystal violet staining assay on cultures grown at 30 °C for 8 h under static conditions. Results are means of at least five technical replicates and error bars represent standard deviations. (b) VPS production by rugose wild-type and *vps* mutants was determined by immunoblot analysis using crude VPS extract spotted on a nitrocellulose membrane and probed with an anti-VPS antiserum. (c) Quantification of VPS production in rugose wild-type and *vps* mutants. Purified VPS was used to quantify VPS production in the strains indicated. Results are means of at least three technical replicates and error bars represent standard deviations. Assays were repeated with two biological replicates.](2757fig4){#f4}

![Biofilm structure analysis of a *vps*-clusters deletion mutant. CSLM images of horizontal (*xy*) and vertical (*xz*) projections (large and side panels, respectively) of biofilm structures formed by rugose wild-type and a mutant strain unable to produce VPS (RΔ*vps*-IΔ*vps*-II) are shown; scale bars represent 40 μm. Assays were repeated with at least two biological replicates.](2757fig5){#f5}

![Intestinal colonization phenotypes of *V. cholerae* wild-type and mutant strains in the infant mouse model. Wild-type smooth and rugose variants and rugose mutant strains lacking the genes required for VPS (RΔ*vps*-IΔ*vps*-II) and matrix protein production (RΔ*rbmA* and RΔ*rbmC*Δ*bap1*) were used in single-strain infections. The data shown are pooled from two experiments, and the horizontal bars indicate the median of each dataset. The asterisks indicate significantly different medians of the recovered c.f.u. compared to the rugose variant as determined by Mann--Whitney *U* test (smooth *P*=0.0354, RΔ*vps*-IΔ*vps*-II *P*=0.0043 and RΔ*rbmA P=*0.0426).](2757fig6){#f6}

###### 

Bacterial strains and plasmids used in this study

  **Strain or plasmid**       **Relevant genotype and phenotype**                                                                **Source**
  --------------------------- -------------------------------------------------------------------------------------------------- ----------------------------
  ***E. coli* strains**                                                                                                          
  CC118*λpir*                 Δ(*ara*-*leu*) *araD* Δ*lacX74 galE galK phoA20 thi*-*1 rpsE rpoB argE*(Am) *recA1λpir*            [@r22]
  S17-1*λpir*                 Tp^r^ Sm^r^*recA thi pro* RP4 : : 2-Tc : : MuKm Tn*7λpir*                                          [@r11]
  ***V. cholerae* strains**                                                                                                      
  FY_Vc_1                     *V. cholerae* O1 El Tor A1552, smooth wild-type variant, Rif^r^                                    [@r55]
  FY_Vc_2                     *V. cholerae* O1 El Tor A1552, rugose wild-type variant, Rif^r^                                    [@r55]
  FY_Vc_234                   RΔ*vps*-I, rugose variant with deletion of *vpsA*--*K*, Rif^r^                                     [@r4]
  FY_Vc_4324                  RΔ*vps*-II, rugose variant with deletion of *vpsL*--*Q*, Rif^r^                                    This study
  FY_Vc_4327                  RΔ*vps*-IΔ*vps*-II, rugose variant with deletion of *vpsA*--*K* and *vpsL*--*Q*, Rif^r^            This study
  FY_Vc_3679                  RΔ*vpsU*, Rif^r^                                                                                   This study
  FY_Vc_2784                  RΔ*vpsA*, Rif^r^                                                                                   This study
  FY_Vc_3682                  RΔ*vpsB*, Rif^r^                                                                                   This study
  FY_Vc_4949                  RΔ*vpsC*, Rif^r^                                                                                   This study
  FY_Vc_2787                  RΔ*vpsD*, Rif^r^                                                                                   This study
  FY_Vc_4974                  RΔ*vpsE*, Rif^r^                                                                                   This study
  FY_Vc_4951                  RΔ*vpsF*, Rif^r^                                                                                   This study
  FY_Vc_3326                  RΔ*vpsG*, Rif^r^                                                                                   This study
  FY_Vc_4954                  RΔ*vpsC*Δ*vpsG*, Rif^r^                                                                            This study
  FY_Vc_4976                  RΔ*vpsH*, Rif^r^                                                                                   This study
  FY_Vc_3374                  RΔ*vpsI*, Rif^r^                                                                                   This study
  FY_Vc_3685                  RΔ*vpsJ*, Rif^r^                                                                                   This study
  FY_Vc_3377                  RΔ*vpsK*, Rif^r^                                                                                   This study
  FY_Vc_3380                  RΔ*vpsL*, Rif^r^                                                                                   This study
  FY_Vc_3688                  RΔ*vpsM*, Rif^r^                                                                                   This study
  FY_Vc_3382                  RΔ*vpsN*, Rif^r^                                                                                   This study
  FY_Vc_3384                  RΔ*vpsO*, Rif^r^                                                                                   This study
  FY_Vc_3691                  RΔ*vpsP*, Rif^r^                                                                                   This study
  FY_Vc_4979                  RΔ*vpsQ*, Rif^r^                                                                                   This study
  FY_Vc_240                   Rugose mTn*7*-*gfp*, Rif^r^ Gm^r^                                                                  [@r5]
  FY_Vc_6226                  RΔ*vps*-IΔ*vps*-II mTn*7*-*gfp*, Rif^r^ Gm^r^                                                      This study
  **Plasmids**                                                                                                                   
  pGP704-*sacB*28             pGP704 derivative, *mob*/*oriT sacB*, Ap^r^                                                        G. Schoolnik
  pAJH9                       pWM91 : : Δ*vps*-I (Δ*vpsA--K*), Ap^r^                                                             [@r33]
  pFY-659                     pGP704-*sacB*28 : : Δ*vps*-II (Δ*vpsL--Q)*, Ap^r^                                                  [@r16]
  pFY-631                     pGP704-*sacB*28 : : Δ*vpsU*                                                                        This study
  pFY-530                     pGP704-*sacB*28 : : Δ*vpsA*                                                                        This study
  pFY-632                     pGP704-*sacB*28 : : Δ*vpsB*                                                                        This study
  pFY-930                     pGP704-*sacB*28 : : Δ*vpsC*                                                                        This study
  pFY-534                     pGP704-*sacB*28 : : Δ*vpsD*                                                                        This study
  pFY-934                     pGP704-*sacB*28 : : Δ*vpsE*                                                                        This study
  pFY-736                     pGP704-*sacB*28 : : Δ*vpsF*                                                                        This study
  pFY-633                     pGP704-*sacB*28 : : Δ*vpsG*                                                                        This study
  pFY-938                     pGP704-*sacB*28 : : Δ*vpsH*                                                                        This study
  pFY-918                     pGP704-*sacB*28 : : Δ*vpsI*                                                                        This study
  pFY-634                     pGP704-*sacB*28 : : Δ*vpsJ*                                                                        This study
  pFY-920                     pGP704-*sacB*28 : : Δ*vpsK*                                                                        This study
  pFY-922                     pGP704-*sacB*28 : : Δ*vpsL*                                                                        This study
  pFY-635                     pGP704-*sacB*28 : : Δ*vpsM*                                                                        This study
  pFY-924                     pGP704-*sacB*28 : : Δ*vpsN*                                                                        This study
  pFY-925                     pGP704-*sacB*28 : : Δ*vpsO*                                                                        This study
  pFY-636                     pGP704-*sacB*28 : : Δ*vpsP*                                                                        This study
  pFY-942                     pGP704-*sacB*28 : : Δ*vpsQ*                                                                        This study
  pMCM11                      pGP704 : : mTn*7*-*gfp*, Gm^r^ Ap^r^                                                               M. Miller and G. Schoolnik
  pUX-BF13                    oriR6K helper plasmid, *mob*/*oriT*, provides the Tn*7* transposition function *in trans*, Ap^r^   [@r3]

###### 

Predicted function of the *vps* gene products and phenotypic characteristics of *vps* mutants

  **Annotation**   **Gene**   **Predicted peptide length**   **Colony corrugation\***   **Pellicle formation†**   **Biofilm formation‡**   **VPS production§**   **Class\|\|**   **Predicted functions/domains¶**
  ---------------- ---------- ------------------------------ -------------------------- ------------------------- ------------------------ --------------------- --------------- --------------------------------------------------------------------
  VC0916           *vpsU*     166                            +\#                        +\#                       ++                       +/−                   V               Phosphotyrosine-protein phosphatase
  VC0917           *vpsA*     372                            −                          −                         \+                       −                     I               UDP-*N*-acetylglucosamine 2-epimerase
  VC0918           *vpsB*     413                            −                          −                         \+                       −                     I               UDP-*N*-acetyl-[d]{.smallcaps}-mannosaminuronic acid dehydrogenase
  VC0919           *vpsC*     184                            \+                         \+                        +++                      +++                   IV              Acetyltransferase
  VC0920           *vpsD*     382                            −                          −                         \+                       −                     II              Glycosyltransferase
  VC0921           *vpsE*     469                            −                          −                         \+                       −                     III             Polysaccharide export
  VC0922           *vpsF*     406                            −                          −                         \+                       −                     VI              Hypothetical protein
  VC0923           *vpsG*     143                            +\#                        +\#                       ++                       \+                    IV              Acetyltransferase
  VC0924           *vpsH*     446                            +\#                        +\#                       ++                       \+                    III             Polysaccharide polymerase
  VC0925           *vpsI*     365                            −                          −                         \+                       −                     II              Glycosyltransferase
  VC0926           *vpsJ*     390                            −                          −                         \+                       −                     VI              Hypothetical protein
  VC0927           *vpsK*     250                            −                          −                         \+                       −                     II              UDP-*N*-acetyl-[d]{.smallcaps}-mannosamine transferase
  VC0934           *vpsL*     465                            −                          −                         \+                       −                     II              Glycosyltransferase
  VC0935           *vpsM*     398                            −                          −                         \+                       −                     VI              Hypothetical protein
  VC0936           *vpsN*     175                            −                          −                         \+                       −                     III             Polysaccharide export
  VC0937           *vpsO*     737                            −                          −                         \+                       −                     III             Polysaccharide polymerase
  VC0938           *vpsP*     235                            \+                         \+                        +++                      ++                    VI              Hypothetical protein
  VC0939           *vpsQ*     144                            \+                         \+                        +++                      +++                   VI              Hypothetical protein

\*Wild-type rugose colony corrugation (+); altered colony morphology with reduced corrugation (+\#); flat and smooth colony morphology (−).

†Wild-type rugose pellicle formation and structure (+); altered pellicle structure (+\#); no pellicle formation (−).

‡Wild-type rugose biofilm formation in crystal violet staining assay (+++); moderate reduction in biofilm formation (++); marked reduction in biofilm formation (+).

§Strong rugose wild-type signal in VPS immunoblot assay (+++); moderate signal (++); weak signal (+); faint signal (+/−); very faint signal (−).

\|\|Classification based on domains and predicted functions.

¶Predicted functions and domains assigned by The Institute for Genomic Research-Comprehensive Microbial Resource (TIGR-CMR) and Universal Protein Resource (UniProt) databases.

###### 

[comstat]{.smallcaps} analysis of biofilms formed by rugose wild-type and RΔ*vps*-I*vps*-II

Values are means (standard deviations) of data from at least six *z*-series image stacks.

  **Strain**           **Time (h)**   **Thickness (μm)**   **Biomass (μm^3^ μm^−2^)**   
  -------------------- -------------- -------------------- ---------------------------- -------------
  Rugose               2              2.4 (1.56)           24.1 (9.07)                  1.7 (1.00)
                       6              6.8 (1.89)           36.4 (9.24)                  5.7 (1.40)
                       24             30.8 (3.65)          60.9 (7.98)                  25.5 (2.97)
  RΔ*vps*-IΔ*vps*-II   2              3.2 (1.80)           10.0 (1.59)                  2.4 (1.30)
                       6              8.6 (1.48)           13.0 (1.91)                  7.5 (1.42)
                       24             8.9 (2.86)           14.3 (3.58)                  7.7 (2.37)
